ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,328, issued on Aug. 5, was assigned to Nanyang Technological University (Singapore) and National University of Singapore (Singapore).

"Biohybrid peptidoglycan oligomers" was invented by Xuewei Liu (Singapore), Bee Eng Mary Chan (Singapore), Hongwei Duan (Singapore), Jingxi He (Singapore), Kim Le Mai Hoang (Singapore) and Liang Yang (Singapore).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a compound of formula Ia and/or formula Ib: or a pharmaceutically acceptable salt, solvate or prodrug thereof, where the groups are defined herein. The invention also relates to a pharmaceutical formulation comprising the compound for treati...